Orthocell (ASX:OCC) was granted a license by the Food and Drug Administration of Thailand to start selling its Remplir nerve repair collagen wrap in the country, according to a Monday Australian bourse filing.
Thailand's nerve repair market has an estimated value of $84 million. It plans to appoint a local on-the-ground specialist distributor.
The firm said it leveraged an expedited registration pathway available for medical devices already approved by the Health Sciences Authority in Singapore.
The firm is considering other potential markets in Asia-Pacific, including Taiwan, Vietnam, Indonesia, and the Philippines.
The company's shares gained about 1% in recent Monday trade.